Search Results - "Galbraith, Paul F."

Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis by Fung, Sarah S., Hillier, Kortney L., Leger, Chantal S., Sandhu, Irwin, Vickars, Linda M., Galbraith, Paul F., Li, Charles H., Leitch, Heather A.

“…Monoclonal B-cell lymphocytosis (MBL) is a clonal lymphoproliferation with the immunophenotype of chronic lymphocytic leukemia (CLL) but a B-lymphocyte count…”
Get full text

Aplastic anemia following administration of a tumor necrosis factor‐α inhibitor by Kuruvilla, John, Leitch, Heather A., Vickars, Linda M., Galbraith, Paul F., Li, Charles H., Al‐Saab, Saad, Naiman, Sheldon C.

“…: Upregulation of tumor necrosis factor‐alpha (TNF‐α) has been implicated in the pathogenesis of several inflammatory conditions, including rheumatoid…”
Get full text

Improved Outcome of Human Immunodeficiency Virus-Associated Plasmablastic Lymphoma of the Oral Cavity in the Era of Highly Active Antiretroviral Therapy: A Report of Two Cases by Lester, Richard, Li, Charles H, Phillips, Peter, Shenkier, Tamara N, Gascoyne, Randy D, Galbraith, Paul F, Vickars, Linda M, Leitch, Heather A

“…Plasmablastic lymphoma (PBL) is a recently described type of non-Hodgkin's lymphoma (NHL) that occurs in up to 3% of patients with HIV infection. Although the…”
Get full text

Acute leukemia in patients sixty years of age and older: a twenty year single institution review by Leger, Chantal S, Leitch, Heather A, Galbraith, Paul F, Li, Charles H, Vickars, Linda M

“…Acute leukemia, particularly acute myeloid leukemia, occurs more frequently in the elderly, a growing segment of the North American population. To evaluate our…”
Get full text

A Scoring System Based on Clinical, Blood Count and Immunophenotypic Data Can Predict the Risk of Disease Progression in Patients with Chronic Lymphocytic Leukemia by Alipour, Sina, Leitch, Heather, Vickars, Linda M, Foltz, Lynda M, Galbraith, Paul F, Leger, Chantal S, Ramadan, Khaled M

“…There is limited access to advanced molecular and immunophenotypic techniques such as immunoglobulin heavy chain variable mutational status and ZAP-70…”
Get full text

CD38 Expression above 20% Predicts Disease Progression in Chronic Lymphocytic Leukemia and Is a Useful Prognostic Marker Where Cytogenetic and Molecular Markers Are Not Available by Alipour, Sina, Leitch, Heather, Vickars, Linda M, Foltz, Lynda M, Galbraith, Paul F, Leger, Chantal S, Ramadan, Khaled M

“…The prognostic significance of CD38 expression and the cut off value has not been fully investigated. As CD38 is readily available test in patients with…”
Get full text

Richter Transformation of Chronic Lymphocytic Leukemia: Incidence, Risk Factors and Outcome by Alipour, Sina, Leitch, Heather, Vickars, Linda M, Foltz, Lynda M, Galbraith, Paul F, Leger, Chantal S, Ramadan, Khaled M

“…Richter transformation (RT) is a rare complication of chronic lymphocytic leukemia (CLL). There is little information in the literature about its risk and…”
Get full text

Improved Survival in Patients with Myelodysplastic Syndrome (MDS) Receiving Iron Chelation Therapy by Leitch, Heather A., Goodman, Trisha A., Wong, Karen K., Vickars, Linda M., Galbraith, Paul F., Leger, Chantal S.

“…Patients (pts) with MDS and iron overload often receive iron chelation therapy (ICT), although there are no data demonstrating that this improves clinical…”
Get full text

Improved Leukemia-Free and Overall Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy: A Subgroup Analysis by Leitch, Heather A., Wong, Dominic H.C., Leger, Chantal S., Ramadan, Khaled M., Rollins, Meaghan D., Barnett, Michael J., Goodman, Trisha A., Wong, Karen K., Galbraith, Paul F., Vickars, Linda M.

“…Myelodysplastic syndrome (MDS) is characterized by ineffective hematopoiesis and risk of progression to acute myeloid leukemia (AML). Many MDS patients (pts)…”
Get full text

Acute Leukemia in Patients Sixty Years of Age and Older: A Retrospective Review by Leger, Chantal S., Lee, Ann, Leitch, Heather A., Galbraith, Paul F., Li, Charles H., Vickars, Linda M.

“…Acute leukemia, especially acute myeloid leukemia (AML), occurs more frequently in the elderly population. Treatment outcomes for this condition have…”
Get full text

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin's Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy by Ezzat, Hatoon, Filipinko, Douglas, Vickars, Linda M., Galbraith, Paul F., Li, Charles H., Murphy, Kevin, Montaner, Julio S.G., Harris, Marianne, Hogg, Robert S., Vercauteren, Suzanne, Leger, Chantal S., Zypchen, Leslie, Leitch, Heather A.

“…EBV infection of B-lymphocytes is known to promote cell proliferation and survival. In contrast to NHL in HIV-negative patients (pts), in whom ≤5% are…”
Get full text

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin's Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled by Ezzat, Hatoon, Wong, Jonathan C., Filipenko, Douglas, Vickars, Linda M., Galbraith, Paul F., Li, Charles H., Murphy, Kevin, Montaner, Julio S.G., Harris, Marianne, Hogg, Robert S., Vercauteren, Suzanne, Leger, Chantal S., Zypchen, Leslie, Leitch, Heather A.

“…Aberrant expression of the cell surface marker CD30 in systemic B-cell HIV-related NHL other than anaplastic large cell lymphoma (ALCL) has been reported. CD30…”
Get full text

Presenting Features Predictive of Long-Term Stability in Chronic Lymphocytic Leukemia by Hillier, Kortney L., Fung, Sarah S., Vickars, Linda M., Leger, Chantal S., Galbraith, Paul F., Li, Charles H., Leitch, Heather A.

“…Prognostic factors to predict an aggressive clinical course in chronic lymphocytic leukemia (CLL) such as CD38, ZAP-70 and IgH mutation status have been well…”
Get full text

Clinical Progression and Outcome of Patients with Monoclonal Lymphocytosis of Undetermined Significance by Fung, Sarah S., Hillier, Kortney L., Vickars, Linda M., Leger, Chantal S., Galbraith, Paul F., Li, Charles H., Leitch, Heather A.

“…Monoclonal Lymphocytosis of Undetermined Significance (MLUS) is a clonal lymphoproliferation, usually of B-cells. MLUS has the immunophenotype of Chronic…”
Get full text

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma by Ezzat, Hatoon, Filipenko, J. Doug, Vickars, Linda M., Galbraith, Paul F., Li, Charles H., Murphy, Kevin, Montaner, Julio, Harris, Marianne, Hogg, Robert, Vercauteren, Suzanne, Leger, Chantal S., Zypchen, Leslie, Leitch, Heather A.

“…BCL-2 expression in diffuse large B cell lymphoma (DLBCL) in HIV-negative patients (pts) is associated with inferior outcome, an effect at least partially…”
Get full text

Improved Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy by Leitch, Heather A., Leger, Chantal S., Goodman, Trisha A., Wong, Karen K., Wong, Dominic H.C., Ramadan, Khaled M., Rollins, Meaghan D., Barnett, Michael J., Galbraith, Paul F., Vickars, Linda M.

“…Patients with myelodysplastic syndrome (MDS) and iron overload (IOL) often receive iron chelation therapy (ICT); however, data on clinical outcomes are…”
Get full text

Immune thrombocytopenic purpura in three patients with preexisting ulcerative colitis by Yoshida, E M, Chaun, H, Freeman, H J, Whittaker, J S, Galbraith, P F

“…Ulcerative colitis (UC) is associated with extraintestinal diseases in numerous target tissues. Associated immune-mediated hematological diseases, however, are…”
Get more information

Aplastic anemia following administration of a tumor necrosis factor-α inhibitor by Kuruvilla, John, Leitch, Heather A., Vickars, Linda M., Galbraith, Paul F., Li, Charles H., Al-Saab, Saad, Naiman, Sheldon C.

Get full text